Utility of a Novel Three-Dimensional and Dynamic (3DD) Cell Culture System for PK/PD Studies: Evaluation of a Triple Combination Therapy at Overcoming Anti-HER2 Treatment Resistance in Breast Cancer
Background: Emergence of Human epidermal growth factor receptor 2 (HER2) therapy resistance in HER2-positive (HER2+) breast cancer (BC) poses a major clinical challenge. Mechanisms of resistance include the over-activation of the PI3K/mTOR and Src pathways. This work aims to investigate a novel comb...
Main Authors: | Anusha Ande, Tanaya R. Vaidya, Bao N. Tran, Michael Vicchiarelli, Ashley N. Brown, Sihem Ait-Oudhia |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2018-05-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fphar.2018.00403/full |
Similar Items
-
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99
by: Serenella Eppenberger-Castori, et al.
Published: (2020-02-01) -
Combined targeting of HER-2 and HER-3 represents a promising therapeutic strategy in colorectal cancer
by: Lena-Christin Conradi, et al.
Published: (2019-09-01) -
Role of HER2 in NSCLC
by: Kun ZHANG, et al.
Published: (2015-10-01) -
A novel treatment strategy of HER2-targeted therapy in combination with Everolimus for HR+/HER2- advanced breast cancer patients with HER2 mutations
by: Li, M., et al.
Published: (2022) -
The potential of panHER inhibition in cancer
by: Xiaochun eWang, et al.
Published: (2015-01-01)